xylazine

Secretary of State Orders Emergency Classification of Xylazine aka “Tranq” as Schedule III Controlled Substance

Delaware Secretary of State Jeff Bullock has placed xylazine, also known as “Tranq”— a non-opioid drug used primarily in veterinary medicine—in Schedule III of the Uniform Controlled Substance Act. Tranq has been used increasingly as an additive in opioid abuse to create a “zombie-like” condition for users. Secretary Bullock’s actions follow a recommendation from the […]




xylazine

Secretary of State Renews Emergency Order Placing Xylazine in Schedule III

Pursuant to 29 Del.C. §10119(3), Delaware Secretary of State Jeff Bullock has renewed an Emergency Order placing xylazine, also known as “Tranq”, temporarily in Schedule III in the state of Delaware. The Emergency Order took effect June 2, 2023, and was effective 120 days. The public threat posed by xylazine continues. Therefore, the renewal of […]



  • Department of State
  • Division of Professional Regulation
  • News
  • "Secretary of State"
  • Schedule III
  • Uniform Controlled Substance Act
  • xylazine